Explore the details of the Boehringer Ingelheim Pharmaceuticals Inc. V. Granules India Limited case under case number 1:25-cv-00663 involving a cause of action for Patent Infringement. Review key information about the parties involved, the patents in question, and the docket entries.

Case Details

Case Number
1:25-cv-00663
Filing Date
May 29, 2025
Cause of Action
Patent Infringement
Status
-
Nature of Suit
Patent - Abbreviated New Drug Application(ANDA)

The following parties are involved in this case, with their respective legal representatives for the case.

NameRepresented By
Boehringer Ingelheim Corporation -
Granules Pharmaceuticals, Inc. -

Patents Involved in the Case

This case involves 4 patents, each of which is central to the dispute. These patents may be subject to claims of infringement, challenges to their validity, or other issues concerning their scope and enforcement.

Application NumberPatent Number
-US11090323B2
-US11833166B2
-US9949998B2
-US10258637B2

Docket Entries

The Docket Entries section provides a chronological list of all significant filings and court actions in this case.

DateDocket EntryType

Set alerts for critical docket entry

May 30, 2025Summons Issued as to Granules India Limited on 5/30/2025; Granules Pharmaceuticals, Inc. on 5/30/2025. (Attachments: # 1 Summons Issued)(scs) (Entered: 05/30/2025)PACER Document
May 29, 2025Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent C. H. Boehringer Sohn AG & Co. KG for Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharma GmbH & Co. KG, Boehringer Ingelheim Pharmaceuticals Inc. filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharma GmbH & Co. KG, Boehringer Ingelheim Pharmaceuticals Inc.. (scs) (Entered: 05/30/2025)PACER Document
May 29, 2025Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,949,998 B2; 10,258,637 B2; 11,090,323 B2; 11,833,166 B2. (scs) (Entered: 05/30/2025)PACER Document
May 29, 2025Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: On or about April 17, 2025. Date of Expiration of Patent: *see form for details.Thirty Month Stay Deadline: 10/17/2027. (scs) (Entered: 05/30/2025)PACER Document
May 29, 2025Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (scs) (Entered: 05/30/2025)PACER Document
May 29, 2025COMPLAINT for Patent Infringement filed against Granules India Limited, Granules Pharmaceuticals, Inc. ( Filing fee $ 405, receipt number ADEDC-4698713.) - filed by Boehringer Ingelheim Pharmaceuticals Inc., Boehringer Ingelheim International GmbH, Boehringer Ingelheim Corporation, Boehringer Ingelheim Pharma GmbH & Co. KG. (Attachments: # 1 Exhibit A-D, # 2 Civil Cover Sheet)(scs) (Entered: 05/30/2025)PACER Document